fda warning compounded peptides bpc-157 Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven being considered for inclusion on the 503A Bulks List. Why does this matter? If these peptides are ultimately What's behind the push to
Description
BPC-157 addresses CAI through multiple mechanisms

doi:10.1503/cmaj.080727
Pain and mobility improvements from BPC-157 often become noticeable between days 5 and 14

While our bodies can store B12 for years, some groups are more susceptible to deficiency, often because of absorption issues rather than diet
the treatment was efficacious and was a fast, feasible, and safe treatment alternative for patients
HUBERMAN: Why certain ones may be advantageous for certain purposes, of course, also highlighting the potential risks and in some case, outright dangers